Research updates
New brain tumor research and news, in plain language. The marks on each item show how far along the evidence is. More marks mean it has been tested more.
1061 item(s). Early-stage animal and lab research is hidden. Tick the box above to include it.
-
Testing spinal fluid and blood samples to look for tumor DNA in people with brain tumors or cancer that has spread
This study is checking whether tumor DNA can be found in spinal fluid and blood.
-
A first test in people of the drug CT-179 for glioblastoma
Doctors are testing a new drug called CT-179 in people with glioblastoma.
-
Adding the drug triapine to radiation for glioblastoma or astrocytoma that has come back
This study tests giving a drug called triapine along with radiation for a brain tumor that has come back.
-
- Lab cells
- Animals
- Review
- Tested in people
A review of immune drug trials in glioblastoma
This paper looks at where trials of immune checkpoint drugs for glioblastoma stand now.
-
- Lab cells
- Animals
- Review
- Tested in people
Limiting fluids after pituitary tumor surgery led to fewer cases of low blood sodium
People who were kept on less fluid after surgery had fewer problems with low blood sodium.
-
- Lab cells
- Animals
- Review
- Tested in people
A gentle drug plan kept one man's brain tumor steady for 3 months
An 85-year-old man who was too frail for standard treatment stayed stable on two low-dose medicines.
-
- Lab cells
- Animals
- Review
- Tested in people
Stress may affect how well immune treatments work
Doctors are asking if heavy stress makes immune cancer drugs work less well.
-
Testing a new drug called GLIX1 in adults whose high grade glioma has come back or grown
This study is testing how safe the drug GLIX1 is, and what dose to use, in adults whose high grade glioma has come back or kept growing.
-
Testing a virus called M032 in children and adults with newly diagnosed diffuse midline glioma
This trial is testing whether a lab made virus, put right into the tumor, is safe for people with this brain tumor after they finish radiation.
-
Testing the drug tovorafenib in Japanese children and young adults with brain tumors
This study is testing a drug called tovorafenib, taken by mouth once a week, in young people in Japan who have certain brain tumors.
-
Testing changed immune cells in people whose glioblastoma has come back
This study tests a new kind of immune cell in people whose glioblastoma has returned.
-
Testing a Pill Called JZP3507 for Grade 2 or 3 Meningioma That Came Back
This trial is testing a pill for people whose grade 2 or 3 meningioma came back after earlier treatment.
-
A study drug called LMP744 for adults whose glioblastoma came back
This study is testing whether a drug called LMP744 can kill glioblastoma tumor cells.
-
A study of several treatments for new and returning glioblastoma
This study looks at more than one treatment for a brain tumor called glioblastoma.
-
Testing a new kind of PET scan for people with a glioma
This study is testing whether a new scan can show a glioma more clearly than an MRI does.
-
Testing a smaller treatment edge in radiosurgery for tumors that spread to the brain
This trial is comparing two sizes of the treated area around a brain tumor during focused radiation.
-
Adding Ruxolitinib to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
This study is testing whether adding a drug called ruxolitinib to usual treatment helps people with newly diagnosed glioblastoma.
-
- Lab cells
- Animals
- Review
- Tested in people
Tumor size and position, not radiation dose, linked to fluid buildup in the brain
In a small look back at 31 patients, fluid buildup in the brain was tied to the tumor's size and location, not to the radiation dose.
-
- Lab cells
- Animals
- Review
- Tested in people
Tumor type may change when radiation helps in babies with medulloblastoma
In this study, the type of tumor a young child had seemed to change whether radiation helped, and when.
-
- Lab cells
- Animals
- Review
- Tested in people
A simple tool to predict fluid buildup in the brain after tumor surgery
Doctors built a computer tool that uses three facts known before surgery to estimate who might get fluid buildup in the brain afterward.